Breaking News

RedHill Biopharma Launches Talicia for H. pylori Infection in UAE

Talicia is the first approved low-dose rifabutin-containing all-in-one combination product in the UAE specifically designed to treat H. pylori.

Author Image

By: Charlie Sternberg

Associate Editor

RedHill Biopharma Ltd. has launched Talicia (omeprazole magnesium, amoxicillin and rifabutin) in the United Arab Emirates (UAE) – making it available by prescription to treat adults with Helicobacter pylori (H. pylori) infection.   H. pylori is a bacteria that can infect the lining of the stomach and duodenum. Infection with H. pylori is a major risk factor for gastric ulcers and stomach cancer.   The commercial launch of Talicia in the UAE triggers RedHill’s eligibility for additional...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters